Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Abstract Background Transarterial chemoembolization (TACE) is the recommended treatment for hepatocellular carcinoma (HCC) patients at Barcelona Clinic Liver Cancer (BCLC) B-stage, whereas sorafenib is an orally administered small molecule target drug for BCLC C-stage. This updated systemic review a...

Full description

Bibliographic Details
Main Authors: Lin Li, Wenzhuo Zhao, Mengmeng Wang, Jie Hu, Enxin Wang, Yan Zhao, Lei Liu
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Gastroenterology
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Sorafenib
Systemic review
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12876-018-0849-0

Internet

http://link.springer.com/article/10.1186/s12876-018-0849-0

Similar Items